BioPharma Dive October 9, 2024
Gwendolyn Wu

The startup, which is building a database of biological interactions found in nature, also secured $60 million in funding from a group of life sciences and tech investors.

Basecamp Research, a biotechnology startup focused on artificial intelligence, has raised $60 million in funding and signed a multi-year collaboration with the Broad Institute of MIT and Harvard.

The London-based company said Wednesday that it will work with the lab of David Liu, a prominent gene editing researcher and biotech entrepreneur, to advance new types of “programmable” genetic medicines. The collaboration aims to invent “novel fusion proteins and other large molecules” that might enable those medicines, it said in a statement. Basecamp did not provide specifics.

The collaboration and funding are steps...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Biotechnology, Investments, Pharma / Biotech, Technology, Trends
The AI Leadership Crisis: Why Chief AI Officers Are Failing (And How To Fix It)
HIMSS25 Tackles AI, Cybersecurity and Workforce Readiness Amid Regulatory Uncertainty
Health Systems Want Deep Guidance from Their Vendors When it Comes to AI, KLAS Finds
"Humans in the loop" make AI work — for now
GenAI and the revolution of drug development

Share This Article